View of The results of titers and duration of the antibodies against SARS-CoV2 spike protein in immunized groups of participants with Covishield and Verocell vaccines

Return to Issue Details The results of titers and duration of the antibodies against SARS-CoV2 spike protein in immunized groups of participants with Covishield and Verocell vaccines Download Download PDF